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The constitutively active catalytic domain of protein kinase C (PKC)d is an apoptotic effector generated by caspase-
3 cleavage of full-length PKCd in response to a wide variety of apoptotic stimuli, including UV radiation. The PKCd
catalytic domain induces apoptosis when ectopically expressed, however, the mechanism of apoptosis induction
is unclear. We constructed a chimeric protein encoding the PKCd catalytic domain fused to a mutated estrogen
receptor ligand-binding domain in order to selectively activate the PKCd catalytic domain. The enzymatic activity of
the PKCd catalytic domain fusion protein was induced in human keratinocytes treated with 4-hydroxytamoxifen,
and its activation triggered loss of mitochondrial membrane potential and apoptosis. The apoptosis was associated
with release of cytochrome c from the mitochondria and caspase activation, and was blocked by caspase inhibitors
and the anti-apoptotic proteins Bcl-2, and Bcl-xL, suggesting a role for mitochondrial pore formation. Consistent
with this, the activated PKCd catalytic domain triggered the redistribution and activation of Bax, a Bcl-2 family
protein that can directly induce cytochrome c release. In summary, despite being an apoptotic effector activated
late in the apoptotic cascade, PKCd also activates upstream components of the death effector pathway to insure the
demise of cells committed to apoptosis.
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The process of apoptosis is carried out by a highly regu-
lated and integrated series of signaling intermediates in-
volving multiple organelles. Apoptosis can be initiated by
DNA damage in the nucleus, stress sensed by the endo-
plasmic reticulum, or death receptor activation at the cell
surface (Ferri and Kroemer, 2001). Initiation of apoptotic
signaling by the internal or intrinsic pathway is regulated in
part by Bcl-2 family proteins (i.e. Bax, Bak) that can directly
trigger the release of proapoptotic mediators from the
mitochondria, and in turn activate the initiator caspase-9 (Da-
nial and Korsmeyer, 2004). Activation of death receptor path-
way directly activates initiator caspases such as caspase-8
(Thorburn, 2004). These two pathways can cross-activate
in certain cells via the caspase-8-mediated cleavage
and mitochondrial translocation of Bid (Esposti, 2002).
Common to apoptosis induced by a wide variety of geno-
toxic agents and death ligands is the activation of the ef-
fector caspases such as caspase-3. The activation of
effector caspases triggers the cleavage of death substrates
that systematically commit the cell to an apoptotic cell fate.
The death substrates cleaved by caspases include nuc-
leases involved in degrading DNA, cell-cycle proteins that
limit cell proliferation, and other caspases that amplify the
caspase proteolytic cascade (Degterev et al, 2003).
Protein kinase C (PKC)d is a widely expressed caspase-3
substrate that becomes activated by proteolysis in re-
sponse to apoptotic stimuli such as DNA damaging drugs,
UV or ionizing radiation, and death ligands (Emoto et al,
1995; Ghayur et al, 1996; Mizuno et al, 1997; Denning et al,
1998; Khwaja and Tatton, 1999; Reyland et al, 1999; Basu
et al, 2001; Brodie and Blumberg, 2003). PKCd belongs
to the PKC family of serine/threonine protein kinases that
consist of at least nine isoforms having either pro- or anti-
apoptotic activities (Gutcher et al, 2003). Classical (a, b, g)
and novel (d, e, Z, y) PKC isoforms can be activated by the
diacylglycerol generated in response to phosphatidylinositol
turnover, however, caspase-mediated cleavage in the hinge
domain can also activate PKC by removing the inhibitory
effect of the pseudosubstrate domain in the regulatory do-
main, and is thus independent of phospholipid hydrolysis
(Stabel and Parker, 1991; Ghayur et al, 1996; Denning et al,
2002). PKCd is an especially noteworthy caspase-3 subst-
rate because expression of the catalytic fragment cleavage
product in several cell types is sufficient to induce
apoptosis (Ghayur et al, 1996; Bharti et al, 1998; Denning
et al, 2002; DeVries et al, 2002; Leverrier et al, 2002; Brodie
and Blumberg, 2003). Despite PKCd being a caspase-3
target cleaved and activated relatively late in the death ef-
fector-signaling pathway, inhibition or targeted inactivation
of PKCd can reduce apoptosis induced by UV radiation,
chemotherapeutic drugs, and oxidative stress (Denning
et al, 1998; Reyland et al, 1999; Leitges et al, 2001; Maj-
umder et al, 2001; Matassa et al, 2001; Denning et al, 2002;
DeVries et al, 2002; Matsumura et al, 2003). Furthermore,
inhibition of PKCd catalytic activation also abrogates ca-
spase activity induced by UV and DNA damaging drugs
(Reyland et al, 1999; Basu et al, 2001; Denning et al, 2002).Abbreviations: PKC, protein kinase C; Tam, 4-hydroxytamoxifen
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Together these results indicate that the cleavage and ac-
tivation of PKCd sets up a positive feedback loop that im-
pinges upon more upstream components of the death
effector pathway, amplifying the caspase cascade and
helping to irreversibly commit cells to die.
In this study, we investigated the signaling pathways ac-
tivated by the PKCd catalytic fragment in human keratin-
ocytes to understand its role in inducing apoptosis. We
found that the PKCd catalytic fragment activated the pro-
apoptotic Bcl-2 family protein Bax and caused release of
cytochrome c, activation of the caspase cascade, and loss
of inner mitochondrial membrane integrity. Since caspase
activation is responsible for cleaving and activating PKCd in
the first place, these results explain the positive feedback
regulation mediated by PKCd in cells committed to undergo
apoptosis.
Results
Inducible activation of the PKCd catalytic fragment Ex-
pression of the PKCd catalytic fragment induces apoptosis
in a wide variety of cells, including retroviral packaging cells
(Denning et al, 2002). In order to generate high titer retro-
virus encoding the PKCd catalytic domain, we constructed
a PKCd catalytic fragment that can be regulated. To gen-
erate PKCdcatD-ER, we fused the PKCd catalytic domain to
a mutant estrogen receptor ligand-binding domain that
binds 4-hydroxytamoxifen (Tam) (Fig 1). This fusion protein
begins immediately after the caspase-3 cleavage site in the
hinge domain of PKCd, and has the estrogen receptor lig-
and-binding domain at its carboxyl terminus. As shown in
Fig 2A, infection of HaCaT cells with a retrovirus encoding
the 78 kDa PKCdcatD-ER fusion protein caused high-level
expression as detected by either a C-terminal PKCd anti-
body or an estrogen receptor antibody. A 43 kDa PKCd
catalytic fragment was also detected with the PKCd anti-
body that probably represents the endogenous PKCd cat-
alytic fragment generated by caspase cleavage, and this
catalytic fragment was increased 1.7-fold by Tam treatment.
To determine if treating cells with Tam induced the
enzymatic activity of the PKCdcatD-ER, we performed
immunoprecipitation kinase assays on the total PKCd in
HaCaT cells expressing either endogenous PKCd (Linker) or
PKCdcatD-ER. As shown in Fig 2B, total basal PKCd activity
was elevated in PKCdcatD-ER-infected cells, and treatment
with Tam for 2 d increased PKCd activity further. No signif-
icant induction of PKCd activity was detected in the control
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Figure 1
Diagram of the protein kinase C (PKC)dcatD-ER fusion protein. Full-length PKCd is cleaved in the hinge domain at DMQD330 # by caspase-3 to
generate an active catalytic domain fragment. PKCdcatD-ER consists of the PKCd catalytic domain beginning at the caspase-3 cleavage site fused
to a mutant estrogen receptor ligand-binding domain (ER) at the carboxyl terminus. To construct PKCdcatD-ER, a methoinine (M) was added to
initiate translation after the cleavage site, and a tryptophan (W) was added at the fusion site to keep the ER in frame.
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Activation of protein kinase C (PKC)dcatD-ER by Tamoxifen. (A) HaCaTcells were infected with either control virus (Linker) or PKCdcatD-ER virus
and treated with 100 nM 4-hydroxytamoxifen (Tam) for 3 d as indicated. The western blot using estrogen receptor (ER) antibody in lanes 1 and 2
shows overexpression of the 78 kDa PKCdcatD-ER fusion protein. The PKCd western blot in lanes 3–5 shows the PKCdcatD-ER and endogenous
PKCd at 78 kDa and the PKCd-cat cleavage product at 43 kDa, especially in the Tam-treated cells. (B) HaCaT cells were infected with control virus
(Linker) or the PKCdcatD-ER virus and treated with Tam for 2 d as indicated. PKCd was immunoprecipitated and total PKC activity assayed. Note the
higher basal PKCd activity in the PKCdcatD-ER cells that was further stimulated by Tam treatment. Similar results were obtained in one additional
experiment.
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Linker-infected HaCaTcells treated with Tam, indicating that
the endogenous PKCd was not responsive to Tam regula-
tion. These results indicate that PKCdcatD-ER enzyme ac-
tivity has elevated basal activity, but is further activated in
cells treated with Tam.
Induction of apoptosis by the PKCd catalytic frag-
ment To determine if the PKCdcatD-ER can induce apop-
tosis, we infected HaCaT keratinocytes with PKCdcatD-ER
and treated them with Tam for 2 d. Figure 3A shows that
there was morphological cell death in the PKCdcatD-ER-
expressing cells in the presence and absence of Tam. The
inactive kinase mutant (K378A) or control vector (Linker) did
not cause any morphological effects, and Tam alone had no
effect. Quantitation of apoptosis by Annexin V staining in Fig
3B shows that the PKCdcatD-ER increased the basal level
of apoptosis about 1.5-fold from 10.1% to 14.7%, but the
addition of Tam significantly increased apoptosis to 37.8%.
The elevated apoptosis in the absence of Tam is consistent
with elevated basal PKCd activity in PKCdcatD-ER-ex-
pressing cells (Fig 2B). The PKCdcatD(K378A)-ER mutant
did not trigger apoptosis, but UV radiation induced massive
(79%) apoptosis. The general caspase inhibitor z-VAD pro-
vided 59% inhibition from UV apoptosis and also inhibited
PKCdcatD-ER apoptosis to approximately the same extent
(60% inhibition), indicating that PKCdcatD-ER apoptosis is
largely caspase dependent.
Expression of the PKCd catalytic fragment also induced
ultrastructural features of apoptosis such as cytoplasmic
vacuolization, membrane blebbing, and nuclear condensa-
tion and fragmentation (Fig 3C). These ultrastructural
changes were evident at 1 d after infection, and by 3 d
were as prominent as those induced 18 h after UV irradi-
ation.
Activation of caspases by the PKCd catalytic frag-
ment To explore the relative contribution of intrinsic and
death receptor pathways in PKCdcatD-ER apoptosis, we
used dominant/negative mutants of caspase-9 and FADD.
In HaCaT cells, the dominant/negative caspase-9 can se-
lectively block the intrinsic apoptotic pathway (i.e. UV),
wheras the FADD dominant/negative inhibits apoptosis
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Figure 3
Induction of apoptosis by the activated protein kinase C (PKC)d catalytic domain. (A) HaCaT cells infected with control (Linker), inactive mutant
PKCdcatD(K378A)-ER, or PKCdcatD-ER viruses were treated with 100 nM 4-hydroxytamoxifen (Tam) for 2 d as indicated. Phase contrast pictures
show morphological cell death only in the PKCdcatD-ER cells. (B) HaCaT cells infected with control (Linker) virus, PKCdcatD(K378A)-ER virus,
PKCdcatD-ER virus, or exposed to UV were treated with Tam or z-VAD as indicated. After 3 d, apoptosis was assayed by Annexin V/PI staining. Note
that the elevated basal apoptosis induced by PKCdcatD-ER was further increased with Tam treatment, and that this was partially blocked by z-VAD.
The data is from three experiments with error bars representing the standard deviation. (C) HaCaT cells infected with either control (Linker) virus or
PKCdcatD virus and examined by transmission electron microscopy at days 1, 2, and 3 after infection for apoptotic changes. Note the progressive
bleb formation and nuclear condensation/fragmentation in the PKCdcatD-infected cells that resembles cells exposed to UV radiation (18 h).
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induced by death receptor activation (Sitailo et al, 2002).
Figure 4A shows that the dominant/negative caspase-9 and
FADD both inhibited apoptosis induced by PKCdcatD-ER to
an equal degree (  35%), indicating that both pathways
may be involved. In contrast, UV-induced apoptosis was
selectively blocked by the caspase-9 dominant/negative
and z-VAD, whereas apoptosis induced by death receptor
activation was inhibited by FADD dominant/negative and
not caspase-9 dominant/negative. z-VAD partially inhibited
apoptosis induced by PKCdcatD-ER plus Tam, confirming
that caspase activity is required for apoptosis induced by
the PKCd catalytic domain.
To directly determine which caspases are activated dur-
ing apoptosis induced by PKCdcatD-ER, we measured ca-
spase enzyme activity using peptide substrates selective for
caspase-2, caspase-3, caspase-8, or caspase-9. As shown
in Fig 4B, PKCdcatD-ER plus Tam induced the activity of
caspase-3, caspase-8, and caspase-9 activity, but not ca-
spase-2. The activity of the initiator caspases, caspase-8
and caspase-9, were increased approximately to the same
extent (  1.4-fold), precluding any assignment of a single
initiator caspase. In contrast, UV induced the activity of
all caspases, including caspase-2. The kinase-inactive
PKCdcatD(K378A)-ER plus Tam did not induce caspase
activation (data not shown). Although not evaluated, we
predict that caspase activation by PKCdcatD-ER without
Tam would be greater than Linker plus Tam but less than
PKCdcatD-ER plus Tam, since the induction of apoptosis
was intermediate (Figs 3B, 4A, and 5A).
Inhibition of PKCd-induced apoptosis by Bcl-2 To further
evaluate the involvement of the intrinsic apoptotic pathway
in PKCd apoptosis, we expressed the anti-apoptotic Bcl-2
in HaCaT cells. Figure 5A shows that apoptosis induced by
PKCdcatD-ER plus Tam was inhibited  54% by Bcl-2 ex-
pression. Expression of full-length PKCd or treating Linker-
infected cells with TPA did not induce apoptosis, but the
combination of full-length PKCd plus TPA-induced 26.1%
apoptosis. Apoptosis induced by full-length PKCd plus TPA
was also inhibited by Bcl-2 (59% inhibition), as was UV-
induced apoptosis (57% inhibition). These results suggest
that the intrinsic death effector pathways play a major role in
apoptosis induced by either PKCd-cat or the activated full-
length PKCd.
The ability of Bcl-2 to inhibit apoptosis by PKCd-cat was
confirmed by measuring loss of mitochondrial membrane
potential. As shown in Fig 5B, Bcl-2, Bcl-xL, and z-VAD all
inhibited the loss of mitochondrial membrane potential in-
duced by PKCd-cat. Bcl-2 was most effective with 82%
inhibition. Bcl-2 and Bcl-xL also slightly reduced the low
level of membrane depolarization in PKCd(K378A)-cat-ex-
pressing cells, although the level of membrane depolariza-
tion in PKCd(K378A)-cat cells was not significantly different
than Linker-infected control cells. Bcl-2 and Bcl-xL over-
expression were confirmed by western blotting (data not
shown).
The PKCd catalytic fragment induces Bax activation and
cytochrome c release The release of cytochrome c from
mitochondria is a triggering event for caspase activation
and is negatively regulated by anti-apoptotic Bcl-2 family
proteins (Cheng et al, 2001). Since Bcl-2 and Bcl-xL blocked
apoptosis induced by PKCdcatD-ER, we investigated the
ability of PKCdcatD-ER to cause cytochrome c release. In
Fig 6A, immunofluorescence staining of cytochrome c in
untreated cells shows a punctate, perinuclear distribution
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Figure 4
Apoptosis induced by the active protein kinase C (PKC)d catalytic domain requires caspase activation. (A) HaCaT cells were infected with
viruses, exposed to UV, treated with the caspase inhibitor z-VAD, treated with 4-hydroxytamoxifen (Tam), and/or treated with anti-Fas plus
cyclohexamide (CH11þCHX) as indicated, and apoptosis assayed by Annexin V staining. Note that the induction of apoptosis by PKCdcatD-
ERþTam was inhibited equally well by caspase-9 D/N (Casp-9 D/N), FADD D/N, and z-VAD. In contrast, caspase-9 D/N selectively blocked UV
apoptosis and FADD D/N only blocked anti-Fas apoptosis. (B) HaCaT cells were infected with the negative control (Linker) virus or PKCdcatD-ER
virus and treated with Tam, or exposed to UV as a positive control, and caspase activity assayed in cell lysates using fluorogenic substrates as
described in Materials and Methods. Note the induction of caspase-3 (2.4-fold), caspase-8 (1.4-fold), and caspase-9 (1.5-fold), but not caspase-2 by
PKCdcatD-ERþTam. UV induced the activity of all caspases assayed, including caspase-2. Error bars for this figure are standard deviation of one
representative experiment performed in triplicate.
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consistent with mitochondrial localization. Cells expressing
PKCdcatD-ER and treated with Tam had a marked redistri-
bution of cytochrome c staining suggesting a perturbation in
mitochondrial architecture. Disruption of mitochondria or-
ganization was confirmed with MitoTraker staining shown in
Fig 7C. In addition, diffuse cytochrome c staining was ev-
ident in cells co-expressing high levels of PKCdcatD-ER
(Fig 6A), suggesting release of cytochrome c into the cy-
toplasm. Cytochrome c remained punctate in HaCaT cells
expressing the inactive PKCdcatD(K378A)-ER, but UV irra-
diation caused cytochrome c to appear diffuse and clumpy.
Cytochrome c release was confirmed in biochemically
fractionated cells by western blots of cytosolic fractions
(Fig 6B). Expression of PKCdcatD-ER plus Tam treatment
increase cytosolic cytochrome c, and this release was
blocked by Bcl-2 and Bcl-xL. Cytochrome c was still re-
leased in the presence of the general caspase inhibitor z-
VAD, consistent with cytochrome c release being upstream
of caspase activation (Adrain et al, 2001). Cytochrome c
release induced by UV was also blocked by Bcl-2 and
Bcl-xL.
The ability of Bcl-2 and Bcl-xL to block cytochrome c
release and apoptosis suggests that pro-apoptotic Bcl-2
family proteins may be involved in initiating apoptosis by the
PKCd catalytic fragment. We examined several Bcl-2 family
proteins and found no change in the total levels of Bcl-2,
Bcl-xL, and Noxa in cells expressing active PKCdcatD-ER
(data not shown). Figure 7A shows that total Bax levels,
however, were elevated 2.5  0.4-fold (N¼3 experiments)
in cells infected with the PKCdcatD-ER virus, and Bax in-
creased further in PKCdcatD-ER-expressing cells treated
with Tam (4.5  1.4-fold, N¼3).
Bax can directly induce the release of cytochrome c from
mitochondria (Jurgensmeier et al, 1998), and oligomerizat-
ion in the mitochondrial membrane is an essential compo-
nent of its activation. PKCdcatD-ER-expressing HaCaT cells
and normal keratinocytes treated with Tam had a modest
but reproducible (three experiments) increase in the Bax
dimer form in membrane extracts (Fig 7B). The UV-positive
control caused a large amount of Bax dimer to form in Ha-
CaT cells and normal keratinocytes, with the trimer form
also visible. PKCdcatD(K378A)-ER plus Tam did not induce
Bax dimer formation in HaCaT cells.
The MitoTraker staining in Fig 7C shows that the active
PKCdcatD-ER also caused a dramatic redistribution of mi-
tochondria from an even, perinuclear ring to an asymmetric
clump at one side of the nucleus. Bax was also redistributed
from a cytoplasmic localization with a ring around the nu-
cleus to a more focal bleb that partially co-localized with the
MitoTraker staining. The inactive PKCdcatD(K378A)-ER did
not cause redistribution of mitochondria or Bax. The Bax
immunofluorescence staining was specific as it was com-
pletely blocked by pre-incubating the Bax antibody with a
competing peptide. Taken together, these data indicate that
the active catalytic domain of PKCd triggers the redistribu-
tion and activation of Bax, cytochrome c release, caspase
activation, and ultimately apoptosis.
Discussion
Since the PKCd catalytic fragment is toxic to many cell
types, we constructed a fusion protein with a mutant est-
rogen receptor ligand-binding domain to allow inducible
activation by treating cells with tamoxifen. Estrogen recep-
tor ligand-binding domain fusion proteins have been used
for the reversible activation of a variety of proteins, and can
function either by the ligand inducing a conformation
change that exposes a functional domain, or by triggering
the displacement of heat shock proteins (Littlewood et al,
1995; Tannour-Louet et al, 2002). The PKCdcatD-ER fusion
protein had elevated basal constitutive enzyme activity and
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Inhibition of protein kinase C (PKC)d catalytic domain-induced apoptosis by anti-apoptotic Bcl-2 family proteins. (A) HaCaT cells were
infected with viruses (Linker, PKCdcatD-ER, PKCd, or Bcl-2) and/or exposed to UV, 4-hydroxytamoxifen (Tam), or TPA as indicated, and assayed for
apoptosis by Annexin V staining. Note that Bcl-2 inhibited apoptosis induced by PKCdcatD-ERþTam, PKCdþTPA, and UV. Error bars represent the
range from two independent experiments. (B) HaCaT cells were infected with viruses and/or exposed to z-VAD as indicated, and mitochondrial
membrane potential assayed as loss of Rhodamine 123 fluorescence. Note that the mitochondrial depolarization induced by PKCd-cat was partially
inhibited by Bcl-2, Bcl-xL, and z-VAD indicating that it is a caspase-dependent event. Error bars represent standard deviation from three ex-
periments. Asterisks denote po0.05 compared with PKCd-cat alone.
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triggered higher basal apoptosis, but the activity and
apoptosis were induced further by treating cells with Tam
(Figs 2–4). The induction of apoptosis was not immediate
upon addition of Tam, and took 2–3 d of exposure before
significant levels of apoptosis could be detected. Since
the kinase inactive mutant PKCdCatD(K378A)-ER did not
induce apoptosis, we conclude that apoptosis requires
enzymatic activity of the PKCdCatD-ER fusion protein, as
was the case for the PKCd-cat (Denning et al, 2002). In fact
the effects of PKCdCatD-ER plus tamoxifen on keratin-
ocytes appear identical and stronger than the effects we
observe using a PKCd-cat construct, indicating that the fu-
sion protein has no additional activities to the PKCd cata-
lytic fragment (Denning et al, 2002).
Apoptosis can also be induced by the activation of full-
length PKCd, and this has been associated with caspase
activation and cytochrome c release in some cell types (Li
et al, 1999; Majumder et al, 2000; Majumder et al, 2001;
Matassa et al, 2001), but not all (Fujii et al, 2000). The ca-
spase dependency of apoptosis induced by PKCdcatD-ER
was demonstrated by assaying caspase activity (Fig 4B),
and by inhibiting caspase activity and apoptosis with z-VAD
and a caspase-9 dominant/negative (Figs 3B and 4A). The
release of cytochrome c and induction of caspase activity
by activation of full-length PKCd has been observed in
some cell types (Li et al, 1999; Majumder et al, 2000; Maj-
umder et al, 2001; Matassa et al, 2001). Caspase-3, ca-
spase-8, and caspase-9 were all activated by PKCdcatD-
ER, but since these caspases can cross-activate each oth-
er, it was not possible to determine which caspase is initially
activated. Of note, UV induced robust activity of caspase-2,
an initiator caspase implicated in pre-mitochondrial events,
but the activation of the PKCd catalytic domain did not ac-
tivate caspase-2 suggesting a non-caspase mechanism for
initiating mitochondrial changes. Activation of caspase-2
by UV has been demonstrated previously, however, its
processing is dependent on caspase-9 (Paroni et al, 2001).
Although caspase-2 was activated by UV, the general ca-
spase inhibitor z-VAD did not bock cytochrome c release
induced by UV.
Both the full-length and catalytic fragment of PKCd can
redistribute to mitochondria (Li et al, 1999; Majumder et al,
2000; Majumder et al, 2001; Matassa et al, 2001; Denning
et al, 2002) and nuclei (Wang et al, 1999; DeVries et al,
2002), and both subcellular localizations may well be in-
volved in apoptotic signaling. Several substrates involved in
apoptosis have been identified for PKCd, including p73b
(Ren et al, 2002), DNA-PK (Bharti et al, 1998), Rad9 (Yoshida
et al, 2003), phospholipid scramblase 1 (Frasch et al, 2000)
and 3 (Majumder et al, 2001), and nuclear lamin B (Cross
et al, 2000). The phosphorylation and association of PKCd
with these targets can explain several apoptotic processes.
For example, plasma membrane phospholipid scramblase 1
and mitochondrial phospholipid scramblase 3 are both
phosphorylated by PKCd and involved in the phosphatidyl-
serine redistribution that occurs in apoptosis (Frasch et al,
2000; Majumder et al, 2001). PKCd cleavage and activation
triggers cytochrome c release and initiates the caspase
cascade, and the PKCd substrates identified to date cannot
explain these effects. Our results indicate that the PKCd
catalytic fragment activates and causes the redistribution of
Bax, which in turn can directly trigger cytochrome c release
(Jurgensmeier et al, 1998). The release of cytochrome c
from mitochondria causes caspase activation via apopto-
some formation (Zou et al, 1999). Since HaCaT cells have
two mutant p53 alleles, our data indicates that the catalytic
fragment of PKCd can initiate apoptosis via an intrinsic
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Figure 6
Activation of the protein kinase C (PKC)d catalytic domain triggers
release of cytochrome c from mitochondria. (A) HaCaT cells were
infected with Linker virus (a and b), PKCdcatD-ER virus (c and d), or
PKCdcatD(K378A)-ER virus (e and f) as indicated, and treated with 4-
hydroxytamoxifen (Tam) (c, d, e, and f) or exposed to UV (b). After 2 d of
Tam treatment, the cells were fixed and stained with either cytochrome
c (a, b, c, and e) or PKCd antibodies (d and f) as indicated. Note the
diffuse cytochrome c staining in the PKCdcatD-ERþTam cells (arrows)
expressing high levels of PKCd indicating release of cytochrome c from
mitochondria. Cells were also treated with z-VAD to prevent UV-irra-
diated cells from detaching, but z-VAD did not block cytochrome c
release (dotted arrows). (B) HaCaT cells were infected with viruses
(Linker, PKCdcatD-ER, Bcl-2, Bcl-xL) and/or treated (UV, z-VAD, Tam)
as indicated, and cytosol fractions prepared. The cytochrome c west-
ern blot shows the greatest release into the cytosolic fraction by UV
radiation and PKCdcatD-ER plus Tam. The cytochrome c release was
inhibited by Bcl-xL and Bcl-2. Note that cytochrome c was still released
in the presence of z-VAD.
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pathway distinct from p53. This paradigm explains how the
PKCd catalytic fragment can activate the intrinsic death ef-
fector pathway resulting in a positive feedback loop be-
tween caspase activation and PKCd activation.
The mechanism of Bax activation by the PKCd catalytic
domain requires its kinase activity, but could be direct or
indirect. The Bcl-2 family proteins are regulated by phos-
phorylation and protein–protein interaction. For example,
phosphorylation of Bcl-2 is required for its anti-apoptotic
function, whereas phosphorylation of Bad inhibits its pro-
apoptotic activity (Datta et al, 1997; Ito et al, 1997). Com-
puter sequence analysis of human Bax-a at low stringency
revealed potential PKC phosphorylation sites at T174 and
T186 near its carboxyl terminus. PKCe can bind to Bax and
inhibits its activation, thus promoting survival of prostate
cancer cells (McJilton et al, 2003). We did not detect any
association between the catalytic domain of PKCd and Bax
by co-immunoprecipitation (data not shown), and thus a
direct protein–protein interaction is unlikely. Bcl-2 family
proteins with multiple BH domains, such as Bax, are
activated by BH3 domain-only proteins (i.e. Bad, Bid, Bim,
Noxa) that function as sensors for apoptotic stimuli (Cory
and Adams, 2002). These BH3 domain-only molecules are
kept inactive by binding to anti-apoptotic family members
(i.e. Bcl-2, Bcl-xL, Mcl-1) (Cheng et al, 2001), and thus it is
possible that the primary target of the PKCd catalytic do-
main is a BH3 domain-only protein or an anti-apoptotic Bcl-
2 family member.
In summary, cleavage and activation of the widely ex-
pressed PKCd occurs in many cells undergoing apoptosis.
This apoptotic effector is known to feed back and stimulate
more upstream components of the death effector pathway
(Li et al, 1999; Majumder et al, 2000; Basu et al, 2001; Maj-
umder et al, 2001; Matassa et al, 2001; Denning et al, 2002;
Leverrier et al, 2002). Our results identify Bax as a target
activated by PKCd that can enhance apoptotic signaling
by causing cytochrome c release and further stimulating
caspase activation. These results have special implications
Figure 7
The protein kinase C (PKC)d
catalytic domain triggers acti-
vation of Bax. (A) HaCaT cells
were infected with either Linker
or PKCdcatD-ER virus, treated
with 4-hydroxytamoxifen (Tam)
as indicated, and whole-cell ly-
sates prepared. The Bax western
blot shows an increase in total
Bax levels in PKCdcatD-ER-in-
fected cells, and a further in-
crease in cells treated with Tam.
(B) HaCaT cells or normal human
keratinocytes were infected with
viruses (Linker, PKCdcatD-ER,
PKCdcatD(K378A)-ER) and treat-
ed with Tam or exposed to UV as
indicated. After cross-linking with
formaldehyde, the cells were
harvested and membrane frac-
tions prepared. The Bax western
blot shows monomer (1  ), dimer
(2  ), and trimer (3  ) forms of
cross-linked Bax. Note the small
but reproducible increase in Bax
dimer by PKCdcatD-ER plus Tam
(lanes 2 and 8), and the dimer and
trimer forms induced by UV (lanes
4 and 6). (C) HaCaT cells were
infected with viruses (Linker,
PKCdcatD-ER, PKCdcatD(K378A)-
ER) and treated with Tam as in-
dicated. The cells were labeled
with MitoTraker Red to stain mi-
tochondria, and then fixed and
stained with antibody to Bax. The
insets shows that Bax staining
was completely prevented with a
blocking peptide. Note the al-
tered localization of mitochondria
and Bax in the PKCdcatD-ER
þTam cells (arrows).
440 SITAILO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
for cells with reduced PKCd levels or activity, such as
keratinocytes with activated ras, since these cells are lack-
ing a critical death effector and may be relatively resistant to
cell death by apoptosis (Denning et al, 1993; Geiges et al,
1995; Denning et al, 1996).
Materials and Methods
Antibodies and chemicals PKCd was detected using an antibody
against the catalytic domain (sc-937, Santa Cruz Biotechnology Inc.,
Santa Cruz, California) at 1:4000 for western blotting and 1:100 for
immunofluorescence. Cytochrome c was detected using a mono-
clonal antibody (556432, BD Biosciences, San Diego, California) at
1:60 for immunofluorescence, and a polyclonal antibody (K2016, BD
Biosciences) at 1:500 for western blotting. Bax was detected with
a polyclonal antibody (sc-493, Santa Cruz Biotechnology Inc.) at
1:500 for western blotting and 1:80 for immunofluorescence. The
mitochondrial probes Rhodamine 123 and MitoTraker Red CMXRos
were from Molecular Probes (Eugene, Oregon). The fluorogenic
substrates for caspase-9 (Ac-LEHD-AFC), caspase-8 (Ac-IETD-
AFC), caspase-3 (Ac-DEVD-AFC), caspase-2 (Ac-VDVAD-AFC),
and the general caspase inhibitor z-VAD-FMK were from Enzyme
Systems Products (Livermore, California). Tam was from Sigma
Chemical Company (St Louis, Missouri).
Caspase and PKC assays Caspase activity was assayed as pre-
viously described (Sitailo et al, 2002). Briefly, attached and floating
cells were lysed in 2  caspase lysis buffer: 25 mM HEPES-NaOH,
pH 7.4, 10% sucrose, 0.1% CHAPS, 2 mM EDTA, 5 mM di-
thiothreitol. Cell lysates were spun in a microfuge, and 50 mg pro-
tein mixed with an equal volume of 2  caspase assay buffer: 25
mM HEPES-NaOH, pH 7.4, 5 mM dithiothreitol; containing 100 mM
final concentration of the appropriate fluorogenic caspase sub-
strate. Assays were incubated at 371C overnight and fluorescence
was measured on a CytoFluor Multi-Well Plate Reader (Perceptive
Biosystems).
For PKC assays, cells were treated and lysed in 20 mM Tris-
HCl, pH 7.4, 2 mM EDTA, 5 mM EGTA, 250 mM sucrose, 5 mM
2-mercaptoethanol, 1  Complete Protease Inhibitor Cocktail
(Boehringer Mannheim, Indianapolis, Indiana), and 0.3% Triton X-
100, and spun in a microfuge. Twenty to 30 mg of protein was
assayed in assay buffer: 50 mM Tris-HCl, pH 7.4, 250 mg per mL
BSA, 1 mM EGTA, 1.5 mM MgCl2, 10 mM of the general PKC
substrate [ser25]peptide (Life Technologies Inc, Gaithersburg, Mar-
yland) in the presence of 25 mM ATP containing 1 mCi [g-32P]ATP.
Reactions were incubated for 10 min at 301C, spotted onto P81
phosphocellulose disks, washed extensively, and the associated
radioactivity counted. Note that these assay conditions contain no
lipids or phorbol esters to activate PKC.
Cell culture and virus infections The immortalized human ker-
atinocyte cell line HaCaT (Boukamp et al, 1988), kindly provided by
Dr Norbert Fusenig (German Cancer Research Center, Heidelberg,
Germany), was cultured in Media 154 (Cascade Biologics Inc.,
Portland, Oregon) with 0.07 mM calcium added. For retroviral in-
fections, cells were plated in six-well plates at 105 cells per well,
and spin infected in the presence of 4 mg per mL polybrene (Hex-
adimethrine Bromide, Sigma Chemical Company). Cells were
washed twice the next morning and fed with Media 154 with or
without 100 nM Tam. In some experiments, cells were infected
once in the morning and then again in the afternoon to introduce
two different viruses. Cells were routinely assayed 3 d after infec-
tion. Experiments using normal human keratinocytes from fore-
skins were approved by Loyola University Medical Center’s
Institutional Review Board.
Cell fractionation and immunoblotting For fractionation into
cytosol and mitochondria-enriched heavy membrane fractions, the
plasma membrane was selectively permeabilized with 0.05%
digitonin (Yi et al, 2003). Cells were trypsinized, washed once in
PBS, and suspended in isotonic sucrose buffer: 250 mM sucrose,
10 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA,
1 mM dithiothreitol, 1  Complete Protease Inhibitor Cocktail.
Digitonin was added to 0.05% final concentration and the cells
mixed gently for 2 min at room temperature. The permeabilized
cells were spun at 750  g at 41C to pellet nuclei and unbroken
cells. The supernatant from this spin was spun at 10,000  g for
25 min at 41C to pellet the heavy membranes, including mito-
chondria. The supernatant was spun at 100,000  g for 1 h at 41C
and this supernatant was taken as the cytoplasmic fraction.
For Bax cross-linking experiments, cells were collected by brief
trypsinization, washed with PBS, and suspended in 160 mL PBS.
Proteins were cross-linked with 0.5% formaldehyde with shaking
at room temperature for 30 min as described (Mikhailov et al,
2001). Cross-linking was quenched by adding 2 volumes of 2%
glycine. The cells were spun, washed with PBS, and suspended in
isotonic sucrose buffer. After permeabilization with 0.05% digitonin
for 2 min at room temperature, the cells were spun at 15,000  g
for 10 min at 41C, and the membrane fraction-containing pellet was
extracted for SDS-PAGE analysis. Whole-cell lysates for western
blotting were prepared by lysing cells in 20 mM Tris-HCl, pH 7.5,
1% Triton X-100, 5 mM EDTA, and 1  Complete Protease Inhib-
itor Cocktail.
DNA constructs and retrovirus production To avoid the toxic
effects of expressing the constitutively active PKCd catalytic frag-
ment, we constructed a retrovirus encoding the human PKCd
catalytic domain under the control of the estrogen receptor ligand-
binding domain (Littlewood et al, 1995). The PKCd catalytic frag-
ment was PCR amplified from pKS-PKCd (Denning et al, 2002),
and cloned in frame into LZRS-MycER containing the modified
estrogen receptor ligand-binding domain of c-MycER (Littlewood
et al, 1995). MycER, kindly provided by Dr Gerard I. Evan (Univer-
sity of California at San Francisco Cancer Center), was cloned into
the EcoRI site of LZRS-Linker (Kinsella and Nolan, 1996; Denning
et al, 2002). The resulting LZRS-MycER was digested with BamHI
to remove c-Myc, and the BamHI-digested PKCd PCR product
was cloned into the BamHI digested LZRS-MycER. The resulting
construct, LZRS-PKCdcatD-ER, has the PKCd catalytic domain
fused to the estrogen receptor ligand-binding domain. A kinase
inactive version, LZRS-PKCdcatD(K378A)-ER, was constructed in
the same fashion using the C3 domain ATP-binding site point mu-
tant pKS-PKCd(K378A) as the template for PCR (Denning et al,
2002). This kinase inactive mutant did not induce apoptosis or
associated biochemical changes in cells treated with Tam, and was
included in several experiments to demonstrate this point (Figs 3A,
B, 5B, 6A, 7B, and C). In some experiments, a virus encoding only
the PKCd catalytic domain (PKCd-cat) was used (Denning et al,
2002).
The Bcl-2 and Bcl-xL retroviruses were constructed by inserting
the cDNAs (provided by Gabriel Nun˜ez, The University of Michigan
Medical School, Ann Arbor, Michigan) for Bcl-2 and Bcl-xL into
LZRS. The Bcl-2 cDNA was cloned into LZRS that had been di-
gested with BamHI, blunted with Klenow, and digested with NotI to
generate LZRS-Bcl-2. The Bcl-xL cDNA was cloned into the EcoRI
site of LZRS-Linker to generate LZRS-Bcl-xL.
Retroviruses were produced in the Phoenix-Ampho packaging
line (ATCC with permission from Garry P. Nolan, Stanford University
Medical Center) by calcium phosphate transfecting the LZRS con-
structs described above. After transfection, cells were selected
and expanded in the presence of 1 mg per mL puromycin, and virus
was harvested from confluent dishes cultured for 24–48 h at 321C.
As a negative control, cells were infected with virus produced from
the empty retroviral vector, LZRS-Linker.
Immunoﬂuorescence For cytochrome c and PKCd immunofluo-
rescence, cells were cultured on glass coverslips, washed with
PBS, and fixed with 3.7% formaldehyde containing 0.05% saponin
for 10 min at room temperature. For MitoTraker Red and Bax
PKCd ACTIVATES BAX AND TRIGGERS APOPTOSIS 441123 : 3 SEPTEMBER 2004
staining, cells were cultured with 100 nM MitoTraker Red for
30 min, washed, and then fixed in –201C acetone/methanol for
10 min. Coverslips were then washed extensively in FA buffer (Di-
fco Labs, Detroit, Michigan) and stained with primary antibodies
in PBS-containing normal goat serum (1:20 dilution) for 1 h at room
temperature. Coverslips were washed again in FA buffer, and
stained with secondary antibody conjugated to Alexa Fluor 488
(Molecular Probes) at 1:400 in PBS-containing normal goat serum
(1:20 dilution). Coverslips were mounted on glass slides in 40%
polyvinyl alcohol (300–70,000 MW) in glycerol, and the cells viewed
with an Olympus AX80 fluorescent microscope (Olympus America,
Inc., Melville, New York).
Flow cytometry Apoptosis was routinely assayed by flow
cytometry using the Annexin V-FITC kit (Beckman Coulter Inc.,
Fullerton, California) as recommended by the manufacturer. The
cells were then run on a Coulter Epics XL-MCL flow cytometer to
determine the percentage Annexin V positive. The percent inhibi-
tion of apoptosis was calculated based on the apoptosis induced
by the treatment (maximum apoptosisbaseline apoptosis).
Mitochondrial membrane potential was measured by Rhoda-
mine 123 fluorescence. After infection and/or treatments, cells
were trypsinized and incubated for 20 min in 1 mL of room tem-
perature media containing 5 mM Rhodamine 123. The cells were
washed with PBS and Rhodamine 123 fluorescence measured by
flow cytometry. Cells with reduced fluorescence were counted as
having lost their mitochondrial membrane potential.
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